Otis Worldwide (NYSE:OTIS – Get Free Report) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Tuesday,Zacks.com reports.
OTIS has been the topic of several other research reports. Wells Fargo & Company boosted their target price on shares of Otis Worldwide from $93.00 to $95.00 and gave the stock an “equal weight” rating in a research report on Monday, October 6th. Morgan Stanley boosted their target price on shares of Otis Worldwide from $97.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 8th. Barclays dropped their target price on shares of Otis Worldwide from $92.00 to $90.00 and set an “underweight” rating on the stock in a research report on Thursday, July 24th. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Otis Worldwide in a research report on Monday, July 14th. They set a “hold” rating and a $109.00 target price on the stock. Finally, Wolfe Research set a $109.00 price objective on shares of Otis Worldwide and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Otis Worldwide has an average rating of “Hold” and a consensus target price of $104.63.
Read Our Latest Report on Otis Worldwide
Otis Worldwide Stock Up 0.7%
Otis Worldwide (NYSE:OTIS – Get Free Report) last released its earnings results on Wednesday, July 23rd. The company reported $1.05 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.02. The company had revenue of $3.60 billion for the quarter, compared to the consensus estimate of $3.73 billion. Otis Worldwide had a net margin of 10.68% and a negative return on equity of 30.95%. Otis Worldwide’s revenue was down .2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.06 EPS. Otis Worldwide has set its FY 2025 guidance at 4.000-4.10 EPS. On average, equities research analysts expect that Otis Worldwide will post 4.04 earnings per share for the current year.
Hedge Funds Weigh In On Otis Worldwide
Large investors have recently made changes to their positions in the company. Kingswood Wealth Advisors LLC acquired a new position in shares of Otis Worldwide in the 1st quarter valued at $225,000. Sowell Financial Services LLC acquired a new position in shares of Otis Worldwide in the 1st quarter valued at $291,000. CWA Asset Management Group LLC acquired a new position in shares of Otis Worldwide in the 1st quarter valued at $262,000. JPMorgan Chase & Co. lifted its stake in shares of Otis Worldwide by 6.7% in the 1st quarter. JPMorgan Chase & Co. now owns 37,920,025 shares of the company’s stock valued at $3,913,347,000 after purchasing an additional 2,396,134 shares during the period. Finally, Cambridge Investment Research Advisors Inc. lifted its stake in shares of Otis Worldwide by 1.2% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 31,673 shares of the company’s stock valued at $3,269,000 after purchasing an additional 371 shares during the period. 88.03% of the stock is currently owned by institutional investors and hedge funds.
About Otis Worldwide
Otis Worldwide Corporation engages in manufacturing, installation, and servicing of elevators and escalators in the United States, China, and internationally. The company operates in two segments, New Equipment and Service. The New Equipment segment designs, manufactures, sells, and installs a range of passenger and freight elevators, as well as escalators and moving walkways for residential and commercial buildings, and infrastructure projects.
See Also
- Five stocks we like better than Otis Worldwide
- The 3 Best Blue-Chip Stocks to Buy Now
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- There Are Different Types of Stock To Invest In
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Otis Worldwide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otis Worldwide and related companies with MarketBeat.com's FREE daily email newsletter.